Cole Pinnow

Insider Reports History

Entity
Individual
Location
C/O Cogent Biosciences, Inc., 275 Wyman Street, 3 Rd Floor, Waltham, MA
Signature
/s/ Evan D. Kearns, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Cole Pinnow:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cogent Biosciences, Inc. Chief Commercial Officer Stock Option (Right to Buy) 240K $1.72M $7.19 Jan 23, 2025 Direct
Cogent Biosciences, Inc. Chief Commercial Officer Common Stock 45.8K $348K $7.60 Jan 14, 2025 Direct

Insider Reports Filed by Cole Pinnow

Symbol Company Period Transactions Value $ Form Type Date Filed Role
COGT Cogent Biosciences, Inc. Jan 23, 2025 1 $0 4 Jan 27, 2025 Chief Commercial Officer
COGT Cogent Biosciences, Inc. Jan 14, 2025 1 $332K 4 Jan 15, 2025 Chief Commercial Officer
COGT Cogent Biosciences, Inc. May 25, 2024 1 $0 4 May 29, 2024 Chief Commercial Officer
COGT Cogent Biosciences, Inc. May 25, 2024 0 $0 3 May 29, 2024 Chief Commercial Officer